Summary : AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein…
Study
-
-
Covid DrugsPharma Science & Research
Alpaca nanobodies potently neutralize SARS-CoV-2 variants
by adminSummary : Researchers at Karolinska Institutet in Sweden have developed a novel strategy for identifying…
-
Boehringer Ingelheim
Boehringer Ingelheim and OSE Immunotherapeutics To Present Biomarker Analyses from the Phase 1 Clinical Trial with First-in-Class SIRPα Inhibitor BI 765063 in Advanced Solid Tumors
by adminSummary : OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE), today announced that early biomarker analyses from the…
-
Summary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based…
-
Global MarketPharma Science & Research
Scancell gains new facilities at The Oxford Science Park
by adminSummary : British biotech company Scancell has expanded its research and development capabilities at one…
-
Summary : The Committee for Medicinal Products for Human Use (CHMP) has provided an initial…
-
Summary : Chicago-based AbbVie has been making major decisions with company-wide impacts. The therapeutic company…
-
Summary : A new study shows why certain NK cells are activated when encountering a…
-
Covid DrugsPharma Science & Research
Antibodies improve in quality for months after COVID-19 vaccination
by adminSynopsis: For at least six months after COVID-19 vaccination, antibodies produced by immune cells become…
-
ChemIntelligenceCovid DrugsPharma Science & Research
COVID Update: Revisiting the Lab-Leak Theory and Under 5 Vaccination
by adminIt’s uncertain if we will ever determine the origins of COVID-19. The current top theories split…